Cargando…
Downregulation of histone methyltransferase SET8 inhibits progression of hepatocellular carcinoma
The expression of lysine methyltransferase SET8, which is involved in carcinogenesis of many types of human cancers through monomethylation of histone H4 lysine 20 (H4K20), is associated with the prognosis of hepatocellular carcinoma (HCC). We performed a functional analysis for SET8 to assess its e...
Autores principales: | Wu, Jianhua, Qiao, Kuangyuan, Du, Yanming, Zhang, Xiaoyun, Cheng, Haichao, Peng, Li, Guo, Zhanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066161/ https://www.ncbi.nlm.nih.gov/pubmed/32161353 http://dx.doi.org/10.1038/s41598-020-61402-7 |
Ejemplares similares
-
The histone methyltransferase SET8 is required for S-phase progression
por: Jørgensen, Stine, et al.
Publicado: (2007) -
miR-502 medaited histone methyltransferase SET8 expression is associated with outcome of esophageal squamous cell carcinoma
por: Wang, Cuiju, et al.
Publicado: (2016) -
Inhibition of histone methyltransferase SETD8 represses DNA virus replication
por: Chen, Lin, et al.
Publicado: (2022) -
miR-502-mediated histone methyltransferase SET8 expression is associated with clear cell renal cell carcinoma risk
por: Zhang, Shenglei, et al.
Publicado: (2017) -
Knockdown of Histone Methyltransferase hSETD1A Inhibits Progression, Migration, and Invasion in Human Hepatocellular Carcinoma
por: Cheng, Xin-sheng, et al.
Publicado: (2016)